Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6

Product Details
Customization: Available
Powder: Yes
Customized: Non-Customized
Diamond Member Since 2016

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Full Customization
The supplier provides full customization services
ODM Services
The supplier provides ODM services
Quality Assurance
The supplier provides quality assurance
to see all verified strength labels (17)
  • Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6
  • Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6
  • Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6
  • Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6
  • Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6
Find Similar Products

Basic Info.

Model NO.
CAS 698387-09-6
Suitable for
Adult
Purity
>98%
Color
White
Grade
Pharmaceutical Grade
Transport Package
Alumininum Foli Bags
Specification
10g, 50g, 200g, 1kg, 5kg
Trademark
hhdpharm
Origin
China

Product Description


Wuhan HHD Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6
 

Basic information:

Density 1.3±0.1 g/cm3
Boiling Point 757.0±60.0 °C at 760 mmHg
Molecular Formula C30H29ClN6O3
Molecular Weight 557.043
Flash Point 411.6±32.9 °C
Exact Mass 556.198975
PSA 112.40000
LogP 5.46
Vapour Pressure 0.0±2.5 mmHg at 25°C
Index of Refraction 1.667


Description:

Neratinib is an irreversible epidermal grow factor receptor (EGFR) inhibitor. It is a small molecule tyrosine kinase inhibitor targeting HER2 and HER1 after lapatinib. It is an irreversible pan erbB receptor tyrosine kinase inhibitor. It can selectively inhibit HER-1 and HER-2 (IC50 = 92 nmol / L and 59 nmol / L, respectively). Clinical studies have shown that it has obvious therapeutic effect on non-small cell lung cancer, colon cancer and breast cancer.

 

Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6Wuhan Hhd Supply Neratinib Powder Pharmaceutical Intermediate Neratinib (HKI-272) CAS 698387-09-6

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier